Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Triple-B Study;Carboplatin-cyclophosphamide Versus Paclitaxel With or Without Atezolizumab as First-line Treatment in Advanced Triple Negative Breast CancerNeoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorderActive, not recruitingPhase 22025-11-26NCT01898117

3 results · Page 1 of 1

Swipe the table sideways for more columns.

49 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Admiraal De Ruyter ZiekenhuisGoesNetherlands15
Albert Schweitzer ZiekenhuisDordrechtNetherlands17
AmphiaBredaNetherlands12
AZVUAmsterdamNetherlands3
BovenIJAmsterdamNetherlands1
Bravis ziekenhuisRoosendaalNetherlands16
Catharina ZiekenhuisEindhovenNetherlands43
Deventer ZiekenhuisDeventerNetherlands11
DiakonessenziekenhuisUtrechtNetherlands1
Dijklander ZiekenhuisHoornNetherlands12
Elisabeth Tweesteden ziekenhuisTilburgNetherlands1
Gelre ziekenhuisApeldoornNetherlands5
Groene HartGoudaNetherlands2
Groene Hart ZiekenhuisGoudaNetherlands14
Haaglanden MCLeidschendamNetherlands1
HagaThe HagueNetherlands2
IJsselland ziekenhuisCapelle aan den IJsselNetherlands1
IkaziaRotterdamNetherlands1
Isala KliniekenZwolleNetherlands3
Jeroen Bosch ziekenhuisEindhovenNetherlands2
Lievensberg ziekenhuisBergen op ZoomNetherlands1
LUMCLeidenNetherlands3
Maasstad ZiekenhuisRotterdamNetherlands20
Martini ZiekenhuisGroningenNetherlands23
Maxima Medisch CentrumEindhovenNetherlands7